Guardant Health
327 hedge funds and large institutions have $4.98B invested in Guardant Health in 2022 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 116 increasing their positions, 100 reducing their positions, and 51 closing their positions.
53% more call options, than puts
Call options by funds: $207M | Put options by funds: $135M
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
35% more capital invested
Capital invested by funds: $3.7B → $4.98B (+$1.29B)
16% more repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 100
0.87% more ownership
Funds ownership: 90.9% → 91.77% (+0.87%)
0% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 51
1% less funds holding
Funds holding: 331 → 327 (-4)
Top Buyers
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
+$65.3M |
| 2 |
Holocene Advisors
New York
|
+$62.5M |
| 3 |
JP Morgan Chase
New York
|
+$42.2M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$29.6M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$27.8M |
Top Sellers
GH Hedge Fund Activity: Q3 2022 in Review
327 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q3 2022, worth a combined $4.98B — up 35% from $3.7B a quarter earlier.
Fund positioning in GH was balanced in Q3 2022: 51 funds opened new positions, 51 closed out, 116 added to existing stakes and 100 trimmed.
The largest buyer was VOYA Investment Management, adding an estimated $65.3M. The largest seller was Allianz Asset Management, exiting entirely with an estimated $50M sold.
- 327 institutional investors held Guardant Health (GH) as of Q3 2022, down from 331 in Q2 2022.
- Funds reported $4.98B of Guardant Health stock for Q3 2022, up 35% quarter-over-quarter.
- 51 funds opened new Guardant Health positions in Q3 2022 and 51 closed out, a net change of 0 holders.
- The largest Guardant Health buyer in Q3 2022 was VOYA Investment Management, an estimated $65.3M added.
- The largest Guardant Health seller in Q3 2022 was Allianz Asset Management, an estimated $50M sold.
Based on aggregated 13F filings for Q3 2022.